人核糖核酸酶抑制因子基因重组腺病毒载体的构建及鉴定

目的构建含有人核糖核酸酶抑制因子（hRI）基因的重组腺病毒载体。方法以含有全长cDNA的pT7-RI为模板,PCR扩增hRI,经T载体克隆后,酶切亚克隆到穿梭质粒pAdTrack—CMV上,在BJ5183细菌内和pAdEasy-1同源重组。筛选阳性克隆,酶切、PCR及测序鉴定,线性化后脂质体法转染293细胞进行包装、扩增。通过观察绿色荧光蛋白（GFP）的表达及PCR扩增目的基因等方法鉴定重组的腺病毒。结果酶切鉴定及PCR结果证明hRI基因重组腺病毒载体构建成功,病毒滴度为1．5×10^10 pfu/ml。结论应用细菌内同源重组法成功构建了含hRI基因的重组腺病毒载体。     

人胎盘核糖核酸酶抑制因子研究

人胎盘核糖核酸酶抑制因子研究崔秀云,田余祥（大连医科大学,大连１１６０２３）关键词人胎盘核糖核酸酶抑制因子人胎盘核糖核酸酶抑制因子（ｈｕｍａｎｐｌａｃｅｎｔａｌｒｉｂｏｎｕｃｌｅａｓｅｉｎｈｉｂｉｔｏｒ,ＰＲＩ）是一种酸性胞溶性蛋白质,分子量为５０ｋ...     

高表达人核糖核酸酶抑制因子的乳腺癌细胞株的建立及其鉴定

目的建立稳定高表达人核糖核酸酶抑制因子（hRI）的真核细胞系：乳腺癌细胞系,为进一步研究hRI抗肿瘤、抗氧化的作用机制奠定实验基础。方法将hRI通过逆转录病毒载体（pLNCX-hRI）经过病毒包装细胞（PA317）包装后的高滴度病毒上清,感染乳腺癌（MCF-7）细胞系,经G418筛选后,运用RT-PCR、Western blot等方法进行鉴定hRI在MCF-7中的高表达。结果hRI克隆到乳腺癌细胞（MCF-7）基因组,并随着基因组稳定高表达hRI。结论利用逆转录病毒载体感染真核细胞后获得高表达hRI的肿瘤细胞株,从而为进一步研究真核细胞内hRI的抗肿瘤作用机制提供条件。     

绿色荧光蛋白基因TuMv病毒表达载体的构建

本研究通过设计引物进行PCR扩增得到绿色荧光蛋白GFP基因,将PCR产物酶切以后与芜菁花叶病毒表达载体相连,得到的阳性克隆通过多对引物组合进行PCR验证及序列测定,说明GFP基因已经连接到该病毒表达载体中,而且没有发生碱基误配及错配。该GFP表达载体的构建为进一步利用TuMv的全长cDNA侵染性克隆进行外源基因的转化奠定了基础。     

核糖核酸酶抑制因子(RI)的融合表达与复性

应用PCR技术从核糖核酸酶抑制因子 (ribonucleaseinhibitor ,RI)的克隆载体pT7 ri中扩增出ri片段 (1 5kb) ,亚克隆到融合表达载体pGEX 2T中 ,并转化感受态大肠杆菌BL2 1.异丙基半乳糖苷 (IPTG)诱导表达的GST RI经SDS PAGE证明分子量约 76kD ,表达量约占菌体蛋白总量 2 0 % .以包涵体形式表达的目的蛋白经尿素变性 ,透析复性得到的产物具有较高的抑制RNaseA的活性(15 0U ml) .复性的融合蛋白于 2 4℃经凝血酶作用 16h ,可被切割成 5 0kD的RI和 2 6kD的GST .     

绿色荧光蛋白标记的表达载体pHis-EGFP的构建

为对重组蛋白的表达进行直观检测并简化蛋白纯化的步骤,构建了能在大肠杆菌中表达融合蛋白的通用表达载体pHis-EGFP。该载体含有源自表达载体pET-32a的T7启动子、终止子和源自质粒pUC18的ColE1复制子与绿色荧光蛋白报告基因。应用该载体成功地表达并纯化了酵母GGDP(geranylgeranyldiphosphate,GGDP)合酶融合蛋白,结果表明所构建的载体是一个实用的表达载体,并建立了离子交换层析和亲和层析两步纯化融合蛋白的方法。     

里氏木霉绿色荧光蛋白表达载体的构建及功能鉴定

为了后续研究里氏木霉(Trichoderma reesei)纤维素酶基因的表达与调控,利用overlap PCR及分子克隆技术构建了含有Col E1原核复制起始位点、氨苄青霉素抗性、里氏木霉的丙酮酸脱羧酶启动子、丙酮酸脱羧酶终止子、潮霉素B抗性的筛选标记并能表达增强型绿色荧光蛋白(Zs Green)的表达载体p LXT-Zs Green。将该载体转化里氏木霉QM9414原生质细胞,使用潮霉素B筛选平板得到阳性转化子,随后使用荧光显微镜在488 nm激发光下观察菌丝,并随机挑取4个转化菌株进行Western-blot验证。结果显示,里氏木霉菌丝体可发出明亮的绿色荧光,而且Western-blot验证了该载体能够在里氏木霉中有效地表达增强型绿色荧光蛋白。上述研究表明,载体p LXT-Zs Green在里氏木霉中能够稳定高效地表达外源基因,为研究里氏木霉的基因表达调控奠定了实验基础。     

宫颈癌患者核糖核酸酶抑制因子基因突变的分析

目的通过对宫颈癌患者血液核糖核酸酶抑制因子(ribonuclease inhibitor,RI)基因RNH的突变分析,探讨RNH基因与肿瘤生长的关系。方法针对RNH全基因序列设计21对引物,PCR扩增后采用SSCP对突变进行检测。结果正常人和宫颈癌患者均扩增出相应的21个条带,未发现异常;经过SSCP分析未发现所收集的18例宫颈癌患者血液中的RNH基因有突变发生。结论尚不能肯定RNH基因的突变是否与肿瘤无关,也不能肯定其他肿瘤没有发生突变。需缩小检测片段进一步实验。     

GFP在绿色荧光裸鼠不同组织中的表达及分析

目的研究外源绿色荧光蛋白（green fluorescent protein,简称GFP）基因在BALB/c绿色荧光裸鼠主要器官组织中的表达及其差异。方法小动物成像系统和RT-PCR方法检测GFP的组织分布以及荧光表达水平情况。结果经活体荧光影像系统观察及PCR方法检测发现GFP可以在裸鼠多个器官组织中表达,其中在胰腺、心脏、全脑、皮肤、睾丸中表达量较高。结论外源绿色荧光蛋白可以在模型动物体内成功表达且稳定遗传,其中在胰腺组织中高表达。     

Functional expression of green fluorescent protein derivatives in Halobacterium salinarum

We investigated the applicability of the green fluorescent protein (GFP) of Aequorea victoria as a reporter for gene expression in an extremely halophilic organism: Halobacterium salinarum. Two recombinant GFPs were fused with bacteriorhodopsin, a typical membrane protein of H. salinarum. These fusion proteins preserved the intrinsic functions of each component, bacteriorhodopsin and GFP, were expressed in H. salinarum under conditions with an extremely high salt concentration, and were proved to be properly localized in its plasma membrane. These results suggest that GFP could be used as a versatile reporter of gene expression in H. salinarum for investigations of various halophilic membrane proteins, such as sensory rhodopsin or phoborhodopsin.     

变形链球菌F-ATPase启动子荧光蛋白载体的构建及表达

目的构建由质子移位膜ATP酶(membrane-bound proton-translocating ATPase,F-ATPase)启动子启动的绿色荧光蛋白报告基因穿梭表达载体,观察其在大肠埃希菌中的表达同时鉴定表达产物。方法以变形链球菌(UA159)基因组为模板,扩增F-ATPase启动子片段,构建由F-ATPase启动子启动的绿色荧光表达载体pFgfp,酶切F-ATPase启动子及绿色荧光蛋白编码基因,连接到穿梭质粒pDL276,构建重组载体pLFgfp。结果重组质粒pLFgfp酶切及基因序列分析证实目的片段成功插入,重组载体转化后的大肠埃希菌有绿色荧光蛋白的表达,并能随着细菌传代继续表达。结论 F-ATPase启动子启动的绿色荧光蛋白穿梭表达载体pLFgfp构建成功,为研究生物膜环境中耐酸菌F-ATPase毒力因子的表达奠定基础。     

Fluorescence assay for the binding of ribonuclease A to the ribonuclease inhibitor protein

Ribonuclease A (RNase A) and the ribonuclease inhibitor protein (RI) form one of the tightest known protein-protein complexes. RNase A variants and homologues, such as G88R RNase A, that retain ribonucleolytic activity in the presence of RI are toxic to cancer cells. Herein, a new and facile assay is described for measuring the equilibrium dissociation constant (K(d)) and dissociation rate constant (k(d)) for complexes of RI and RNase A. This assay is based on the decrease in fluorescence intensity that occurs when a fluorescein-labeled RNase A binds to RI. To allow time for equilibration, the assay is most readily applied to those complexes with K(d) values in the nanomolar range or higher. Using this assay, the value of K(d) for the complex of RI with fluorescein-labeled G88R RNase A was determined to be 0.55 +/- 0.03 nM. In addition, the value of K(d) was determined for the complex of RI with unlabeled G88R RNase A to be 0.57 +/- 0.05 nM by using a competition assay with fluorescein-labeled G88R RNase A. Finally, the value of k(d) for the complex of RI with fluorescein-labeled G88R RNase A was determined to be (7.5 +/- 0.4) x 10(-3) s(-1) by monitoring the increase in fluorescence intensity upon dissociation. This assay can be used to characterize complexes of RI with a wide variety of RNase A variants and homologues, including those with cytotoxic activity.     

绿色荧光报告基因在细胞免疫检测中的应用

将丙肝病毒C E1区基因插入绿色荧光报告基因pEGFP-N1中,构建真核表达重组质粒pEGFP-N1-HCV/C E1。转染小鼠骨髓瘤细胞SP2/0,在荧光显微镜下观察绿色荧光融合蛋白的表达情况。结果在细胞浆中出现了绿色荧光,表明目的基因得到表达,再通过G418筛选后大量培养用作细胞毒实验的靶细胞,结果表明以EGFP报告基因作筛选标记制备的靶细胞完全可以满足细胞毒实验要求。     

Transient expression of the green fluorescent protein in pollen

 ZM13 is a pollen-specific maize gene which is expressed in the late stages of pollen development. We wished to utilize the ZM13 promoter to examine the expression of a synthetic green fluorescent protein (SGFP) in germinating pollen. The usefulness of the SGFP expression product is that its appearance and distribution can be monitored non-destructively in vivo. A plasmid containing the SGFP coding region under the control of the ZM13 promoter was constructed and then transiently transformed into pollen of Tradescantia paludosa and Nicotiana tabacum by the use of microprojectile bombardment. The expression of the green fluorescent protein was analyzed by fluorescence microscopy using a fluorescein filter. Expression began about 3 h post-bombardment, and all parts of the pollen grain and tube fluoresced. High levels of fluorescence were observed for several days following treatment. Received: 15 February 1998 / Revision accepted: 22 April 1998     

Inhibition of human pancreatic ribonuclease by the human ribonuclease inhibitor protein

The ribonuclease inhibitor protein (RI) binds to members of the bovine pancreatic ribonuclease (RNase A) superfamily with an affinity in the femtomolar range. Here, we report on structural and energetic aspects of the interaction between human RI (hRI) and human pancreatic ribonuclease (RNase 1). The structure of the crystalline hRI x RNase 1 complex was determined at a resolution of 1.95 A, revealing the formation of 19 intermolecular hydrogen bonds involving 13 residues of RNase 1. In contrast, only nine such hydrogen bonds are apparent in the structure of the complex between porcine RI and RNase A. hRI, which is anionic, also appears to use its horseshoe-shaped structure to engender long-range Coulombic interactions with RNase 1, which is cationic. In accordance with the structural data, the hRI.RNase 1 complex was found to be extremely stable (t(1/2)=81 days; K(d)=2.9 x 10(-16) M). Site-directed mutagenesis experiments enabled the identification of two cationic residues in RNase 1, Arg39 and Arg91, that are especially important for both the formation and stability of the complex, and are thus termed "electrostatic targeting residues". Disturbing the electrostatic attraction between hRI and RNase 1 yielded a variant of RNase 1 that maintained ribonucleolytic activity and conformational stability but had a 2.8 x 10(3)-fold lower association rate for complex formation and 5.9 x 10(9)-fold lower affinity for hRI. This variant of RNase 1, which exhibits the largest decrease in RI affinity of any engineered ribonuclease, is also toxic to human erythroleukemia cells. Together, these results provide new insight into an unusual and important protein-protein interaction, and could expedite the development of human ribonucleases as chemotherapeutic agents.